Antitumor Pentamethylcyclopentadienyl Rhodium Complexes of Maltol and Allomaltol: Synthesis, Solution Speciation and Bioactivity by Dömötör, Orsolya et al.
1 
Antitumor Pentamethylcyclopentadienyl Rhodium Complexes of Maltol 
and Allomaltol: Synthesis, Solution Speciation and Bioactivity 
 
Orsolya Dömötöra, Sabine Aicherb, Melanie Schmidlehner b, Maria S. Novak b, 
Alexander Roller b, Michael A. Jakupec b,c, Wolfgang Kandiollerb,c, Christian G. 
Hartingerd, Bernhard K. Kepplerb,c, Éva A. Enyedya* 
 
a Department of Inorganic and Analytical Chemistry, University of Szeged, Dóm tér 7, H-6720 Szeged, Hungary 
b Institute of Inorganic Chemistry, University of Vienna, Waehringer Str. 42, A-1090 Vienna, Austria 
c University of Vienna, Research Platform Translational Cancer Therapy Research, Waehringer Str. 42, A-1090 
Vienna, Austria 
d School of Chemical Sciences, The University of Auckland, PB: 92019, 1142 Auckland, New Zealand 
 
 
 
 
 
 
Keywords: Stability Constants; Equilibria; Cytotoxicity; X-ray Crystal Structure; Hydroxypyrones; 
Rhodium(III) 
 
 
 
 
* Corresponding author: Fax: +36 62 420505 
E-mail address: enyedy@chem.u-szeged.hu (E. A. Enyedy)
2 
ABSTRACT 
 
The reaction of the dimer [RhIII(pentamethylcyclopentadienyl)(m-Cl)Cl]2 ([Rh
III(Cp*)(m-
Cl)Cl]2) with the hydroxypyrone ligands maltol and allomaltol affords complexes of the 
general formula [RhIII(Cp*)(L)Cl] under standard and microwave conditions. The 
organometallic compounds were characterized by standard analytical methods and in the case 
of the allomaltol derivative in the solid state by single-crystal X-ray diffraction analysis. The 
complexes showed similar cytotoxicity profiles and were proved to be moderately active 
against various human cancer cell lines. The stoichiometry and stability of these complexes 
were determined in aqueous solution by pH-potentiometry, 1H NMR spectroscopy and UV-
visible spectrophotometry. Speciation was studied in the presence and in the absence of 
chloride ions. Hydrolysis of [RhIII(Cp*)(H2O)3]
2+ gave dimeric mixed hydroxido species 
[(RhIII(Cp*))2(m-OH)3]
+ and [(RhIII(Cp*))2(m-OH)2Z2] (Z = H2O/Cl
‒). Formation of the 
mononuclear complexes [RhIII(Cp*)(L)Z] of maltol and allomaltol with similar and moderate 
stability was found. These species predominate at physiological pH and decompose only 
partially at micromolar concentrations. In addition, hydrolysis of the aqua complex or the 
chlorido/hydroxido co-ligand exchange resulted in the formation of the mixed-hydroxido 
species [RhIII(Cp*)(L)(OH)] in the basic pH range. Replacement of the chlorido by an aqua 
ligand in the complex [RhIII(Cp*)(L)Cl] was monitored and with the help of the equilibrium 
constants the extent of aquation at various chloride concentrations of the extra- and 
intracellular milieu can be predicted. Complexation of these RhIII complexes was compared to 
analogous [RuII(h6-p-cymene)] species and higher conditional stabilities were found in the 
case of the RhIII compounds at pH 7.4. 
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1. Introduction 
 
In spite of the clinical success of cisplatin, cis-diamminedichloridoplatinum(II), and its 
derivatives there is an on-going demand for the development of novel types of antitumor 
agents due to the two main disadvantages of these Pt-containing drugs; namely the low 
efficacy against widespread tumors, intrinsic and acquired resistance of neoplams and severe 
side effects accompanying tumors [1-3]. In this context, complexes of the neighboring 
transition metals such as Ru, Os, Ir and Rh have received considerable attention as possible 
alternatives to Pt anticancer agents. The most promising metal-based anticancer drug 
candidates in clinical trials are the RuIII-based trans-[tetrachlorido(1H-
imidazole)(dimethylsulfoxide-κS)ruthenate(III)] (NAMI-A) being active against metastases 
[4], indazolium trans-[tetrachloridobis(1H-indazole)ruthenate(III)] complexes KP1019 [5] 
and its sodium analogue KP1339 [6], which are active against a variety of solid tumors. These 
Ru compounds exhibit low general toxicity, which contrasts to the pharmacological properties 
of Pt drugs. Organometallic half-sandwich h-arene (such as p-cymene, biphenyl) or h-
cyclopentadienyl complexes of Ru and Os are extensively investigated, however relatively 
few studies are focused on related Rh(II/III) compounds with antitumor activity [7-9]. The 
anticancer properties of RhCl3 have been known for many decades [10]. Simple complexes 
such as mer-[RhCl3(NH3)3] or mer,cis-[RhCl3(DMSO)2(NH3)] were also found to be 
anticancer active in vivo [11,12]. Various dirhodium(II,II) complexes have also been reported 
by Dunbar et al. such as carboxylates which are able to inhibit cell viability of the human 
cancer cells and DNA was found to be their cellular target via the potentially intercalation 
forming DNA interstrand cross-links [13,14]. Numerous half-sandwich complexes of Rh such 
as [(h5-C5Me5)Rh(LL)Cl], where (LL) is a bidentate polypyridyl ligand, were prepared as 
well and their antiproliferative properties in human cancer cell lines were tested by Sheldrick 
and co-workers [15-17]. RhIII is isoelectronic with RuII and PtIV, air-stable and forms low-spin 
complexes. [Rh(H2O)6]
3+ features slow ligand exchange processes which may be related to 
the low interest in RhIII compounds for anticancer drug development [7]. The kinetic inertness 
can be overcome via the coordination of neutral arene or especially by anionic 
(pentamethyl)cyclopentadienyl ligands [7]. The nature of the co-ligands in the half-sandwich 
complexes strongly affects the stability, reactivity and biological activity. On the other hand, 
metallodrugs are generally considered as prodrugs and thus can undergo transformation 
processes in the aqueous phase under physiological conditions [18]. Therefore, the knowledge 
of their speciation and the most plausible chemical species formed in aqueous solution in the 
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biologically relevant pH range is a mandatory prerequisite for understanding the alterations in 
their biological activity [19]. 
Recently, we reported Rh(III)-η5-pentamethylcyclopentadienyl [RhIII(Cp*)] complexes 
bearing 3-hydroxyflavone ligands but their anticancer activity could not be tested as a result 
of the very limited solubility in aqueous solution [20]. Hydroxyflavone compounds can be 
considered as derivatives of the 3-hydroxy-4-pyrone such as the naturally occurring 3-
hydroxy-2-methyl-pyran-4(1H)-one (maltol). In vitro biological tests show moderate 
cytotoxicity of [RuII(h6-p-cymene)] complexes of hydroxypyrones against cancer cells [21-
23], but no data are available for analogous [RhIII(Cp*)] complexes. In the present work, we 
report the [RhIII(Cp*)(L)Cl] complexes of maltol and 5-hydroxy-2-methyl-pyran-4(1H)-one 
(allomaltol) (Chart 1) and their biological activity in human cancer cells. Solution equilibria 
of these metal complexes were studied in detail by the combination of various methods such 
as pH-potentiometry, UV-visible (UV-Vis) and 1H NMR spectroscopy in order to determine 
the stoichiometry and stability of complexes formed in aqueous solution. The chlorido/aqua 
co-ligand exchange reactions in the species [RhIII(Cp*)(L)Cl] of maltol and allomaltol was 
also monitored, which may affect the biological activity as in case of [RuII(h6-p-
cymene)(L)Cl] complexes [24]. Stability constants of the complexes were determined in the 
presence and in the absence of chloride ions. Hydrolysis of [RhIII(Cp*)(H2O)3]
2+ (Chart 1) 
was explored under various chloride concentrations.  
Chart 1 
 
2. Experimental 
 
2.1. Chemicals 
 
All solvents were of analytical grade and used without further purification. Maltol, sodium 
methoxide, KCl, KNO3, AgNO3, HCl, HNO3 and KOH were purchased from Sigma-Aldrich 
and used without further purification. Allomaltol [25], dimeric rhodium precursor 
[RhIII(Cp*)(m-Cl)Cl]2 and chlorido[2-methyl-3-(oxo-κO)-pyran-4(1H)-onato-κO](η
5-
1,2,3,4,5-pentamethylcyclopentadienyl)rhodium(III) (1a) were prepared according to 
literature procedures [26,27]. Microwave-assisted reactions were performed in a CEM 
Explorer 12 Hybrid apparatus. Melting points were determined with a Büchi Melting Point B-
540 apparatus. Elemental analyses were carried out with a Perkin Elmer 2400 CHN Elemental 
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Analyser by the Microanalytical Laboratory of the University of Vienna. NMR spectra were 
recorded at 25 °C using a Bruker FT-NMR spectrometer Avance IIITM 500 MHz. 1H-NMR 
spectra were measured at 500.10 MHz and 13C{1H}-NMR spectra at 125.75 MHz in d4-
MeOH. The 2D NMR spectra were measured in a gradient-enhanced mode. The exact 
concentration of the ligand stock solutions together with the proton dissociation constants 
were determined the by pH-potentiometric titrations with the help of the computer program 
HYPERQUAD [28]. A stock solution of [RhIII(Cp*)Z3] (where Z = H2O and/or Cl
−; charges 
are omitted for simplicity) was obtained by dissolving a known amount of [RhIII(Cp*)(m-
Cl)Cl]2 in water, while the stock solution of [Rh
III(Cp*)(H2O)3](NO3)2 was obtained from an 
aqueous solution of [RhIII(Cp*)(m2-Cl)Cl]2 after removal of chloride ions using equivalent 
amounts of AgNO3. The exact concentrations of the [Rh
III(Cp*)] stock solutions (with or 
without chloride) were checked by pH-potentiometric titrations with refinement of the 
stability constants for [RhIII2(Cp*)2(hydroxido)i] (i = 2 or 3) complexes.  
  
2.2. pH-Potentiometric measurements 
 
The pH-potentiometric measurements for determination of the proton dissociation constants 
of the ligands and the overall stability constants of the RhIII-Cp* complexes were carried out 
at 25.0 ± 0.1 °C in water and at an ionic strength of 0.20 M KCl or KNO3 used for keeping the 
activity coefficients constant. The titrations were performed with carbonate-free KOH 
solution (0.20 M). The exact concentrations of HCl, HNO3 and KOH solutions were 
determined by pH-potentiometric titrations. An Orion 710A pH-meter equipped with a 
Metrohm combined electrode (type 6.0234.100) and a Metrohm 665 Dosimat burette were 
used for the pH-potentiometric measurements. The electrode system was calibrated to the pH 
= −log[H+] scale by means of blank titrations (strong acid vs. strong base: HCl/HNO3 vs. 
KOH), as suggested by Irving et al. [29]. The average water ionization constant, pKw, was 
determined as 13.76 ± 0.01 at 25.0 °C, I = 0.20 M (KCl, KNO3), which corresponds well to 
the literature [30]. The reproducibility of the titration points included in the calculations was 
within 0.005 pH units. The pH-potentiometric titrations were performed in the pH range 
2.0−11.5. The initial volume of the samples was 10.0 mL. The ligand concentration was 
1.0−2.0 mM and metal ion-to-ligand ratios of 1:1 to 1:3 were used. The accepted fitting of the 
titration curves was always less than 10 mL. Samples were degassed by bubbling purified 
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argon through them for ca. 10 min prior to the measurements and it was also passed over the 
solutions during the titrations. 
  The computer program PSEQUAD [31] was utilized to establish the stoichiometry of 
the complexes and to calculate the overall stability constants. MpLqHr is defined for the 
general equilibrium: 
pM + qL + rH  MpLqHr as (MpLqHr) = [MpLqHr]/[M]
p[L]q[H]r  (1) 
where M denotes the metal moiety [RhIII(Cp*)] and L the completely deprotonated ligand. 
Log values of the various [RhIII(Cp*)(hydroxido)] complexes were calculated based on the 
pH-potentiometric titration data in the absence and presence of chloride ions. In all 
calculations exclusively titration data were used from experiments in which no precipitate was 
visible in the reaction mixture. 
 
2.3. UV–Vis spectrophotometric and 1H NMR measurements 
 
A Hewlett Packard 8452A diode array spectrophotometer was used to record the UV-Vis 
spectra in the interval 200–800 nm. The path length was 1 cm. The spectrophotometric 
titrations were performed with samples containing only the ligands (0.1 mM), [RhIII(Cp*)Z3] 
(0.16 mM) or a 1:1 molar ratio of [RhIII(Cp*)Z3] and ligand (0.22 mM) over the pH range 
2.0–11.5 at an ionic strength of 0.20 M (KCl or KNO3) and at 25.0 ± 0.1 °C. UV-Vis spectra 
were also recorded to study the H2O/Cl
− exchange processes in the [RhIII(Cp*)(L)Z] 
complexes at pH 7.40 (maltol) or 7.05 (allomaltol) in dependence of the Cl− concentration (0–
280 mM). Stability constants for this exchange process were calculated with the computer 
program PSEQUAD [31]. 
1H NMR studies were carried out on a Bruker Ultrashield 500 Plus instrument. 4,4-
Dimethyl-4-silapentane-1-sulfonic acid was used as an internal NMR standard. The ligands 
were dissolved in a 10% (v/v) D2O/H2O mixture to yield a concentration of 1 or 2 mM and 
were titrated at 25 °C, at I = 0.20 M (KCl or KNO3) in absence or presence of [Rh
III(Cp*)Z3] 
at 1:1 or 1:2 metal-to-ligand ratios.  
 
2.4. Synthesis of [RhIII(Cp*)] complexes of maltol and allomaltol 
 
Chlorido[2-methyl-3-(oxo-κO)-pyran-4(1H)-onato-κO](η5-1,2,3,4,5-
pentamethylcyclopentadienyl)rhodium(III) 1a 
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Microwave-assisted synthesis: 3-Hydroxy-2-methyl-pyran-4(1H)-one (23 mg, 0.18 mmol, 1 
eq) and sodium methoxide (11 mg, 0.20 mmol, 1.1 eq) were dissolved in dry methanol (4 mL) 
and stirred for 15 min in a microwave vial. [RhIII(Cp*)(m-Cl)Cl]2 (50 mg, 0.08 mmol, 0.9 eq) 
was added in one portion and the reaction vessel was placed in the microwave instrument. 
The reaction mixture was irradiated for 30 s with a final temperature of 60 °C (max. 10 W). 
The solvent was removed under reduced pressure, the residue was dissolved in CH2Cl2 and 
the solution was filtered. The volume was reduced to ~2 mL and diethyl ether was added. The 
mixture was stored overnight at 4 °C and the formed crystals were seperated by filtration and 
dried in vacuo (46 mg, 71%).  
Mp: > 178 °C (decomp.); 1H NMR (500.10 MHz, d4-MeOH): δ = 1.72 (s, 15H, -CH3,Cp*), 
2.43 (s, 3H, -CH3,Pyr), 6.58 (d, 1H, 
3J(H,H) = 6 Hz, H4), 7.91 (d, 1H, 3J(H,H) = 6 Hz, H5); 13C 
NMR (125.75 MHz, d4-MeOH): δ = 7.4 (-CH3,Cp*), 13.1 (-CH3,Pyr), 92.1 (CCp*), 113.5 (C5), 
153.3 (C6), 154.1 (C2), 156.2 (C3), 182.0 (C4); Elemental analysis calcd. (%) for 
C16H20ClO3Rh·0.25H2O: C 47.14, H 5.19 found C 47.28, H 4.79. 
 
Chlorido[2-methyl-5-(oxo-κO)-pyran-4(1H)-onato-κO](η5-1,2,3,4,5-
pentamethylcyclopentadienyl)rhodium(III) 1b 
Standard procedure: 5-Hydroxy-2-methyl-pyran-4(1H)-one (91 mg, 0.72 mmol, 1 eq) and 
sodium methoxide (43 mg, 0.79 mmol, 1.1 eq) were dissolved in dry methanol (20 mL) and 
[RhIII(Cp*)(m-Cl)Cl]2 (200 mg, 0.32 mmol, 0.9 eq) was added in one portion. The obtained 
deep red solution was stirred for 18 h at room temperature. The solvent was removed under 
reduced pressure; the residue was dissolved in CH2Cl2, filtered, concentrated and precipitated 
with diethyl ether. The orange product was separated by filtration and dried in vacuo (116 mg, 
45%). 
 
Microwave-assisted synthesis: 5-Hydroxy-2-methyl-pyran-4(1H)-one (23 mg, 0.18 mmol, 1 
eq) and sodium methoxide (11 mg, 0.20 mmol, 1.1 eq) were dissolved in dry methanol (3-4 
mL) and stirred for 15 min in a microwave vial. [RhIII(Cp*)(m-Cl)Cl]2 (50 mg, 0.08 mmol, 0.9 
eq) was added in one portion and the reaction vessel was placed in the microwave instrument. 
The reaction mixture was irradiated for 30 s (max. 10 W) with a final temperature of 60 °C. 
The solvent was removed under reduced pressure, the residue dissolved in CH2Cl2 and 
filtered. The volume was reduced to ~2 mL and diethyl ether was added. The mixture was 
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stored overnight at 4 °C and the formed crystals were collected by filtration and dried in 
vacuo (46 mg, 71%). 
 
Mp: >213 °C (decomp.); 1H NMR (500.10 MHz, d4-MeOH): δ = 1.72 (s, 15H, -CH3,Cp*), 2.34 
(s, 3H, -CH3,Pyr), 6.46 (s, 1H , H4), 7.75 (s, H5);
 13C NMR (125.75 MHz, d4-MeOH): δ = 7.4 
(-CH3,Cp*), 18.1 (-CH3Pyr), 92.1 (CCp*), 109.5 (C5), 141.2 (C6), 157.6 (C2), 166.7 (C3), 184.6 
(C4); Elemental analysis calcd. (%) for C16H20ClO3Rh·H2O: C 46.11, H 5.32 found C 45.90, 
H 4.91. 
 
2.5. Crystallographic structure determination 
 
For X-ray diffraction analysis single crystals of 1b were obtained by using the slow diffusion 
method from CH2Cl2/diethyl ether. The single crystals were analyzed on a Bruker D8 Venture 
diffractometer at 100 K. The single crystal was positioned at 45 mm from the detector and 
1363 frames for 16 s exposure time over 0.4° scan width were measured. The data were 
processed using the SAINT software package [32]. The structures were solved by direct 
methods and refined by full-matrix least-squares techniques. Non-hydrogen atoms were 
refined with anisotropic displacement parameters. Hydrogen atoms were inserted at calculated 
positions and refined with a riding model. The following computer programs were used: 
structure solution, SHELXS-97 [33]; refinement, SHELXL-2013 [33]; OLEX2 [34]; 
SHELXLE [35]; molecular diagrams, ORTEP-3 [36]; scattering factors [37]. The 
crystallographic data files for 1b have been deposited with the Cambridge Crystallographic 
Database as CCDC 966490. 
 
2.6. Cell lines and culture conditions, cytotoxicity tests in cancer cell lines 
 
Cell lines and culture conditions: CH1 cells originate from an ascites sample of a patient with 
an adenocarcinoma of the ovary and were a gift from Lloyd R. Kelland, CRC Centre for 
Cancer Therapeutics, Institute of Cancer Research, Sutton, UK. SW480 (human 
adenocarcinoma of the colon) and A549 (human non-small cell lung cancer) cells were 
provided by Brigitte Marian (Institute of Cancer Research, Department of Medicine I, 
Medical University of Vienna, Austria). All cell culture reagents were obtained from Sigma-
Aldrich Austria and plastic ware from Starlab Germany. Cells were grown in 75 cm² culture 
flasks (Iwaki) as adherent monolayer cultures in Minimum Essential Medium (MEM) 
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supplemented with 10% heat inactivated fetal calf serum, 1 mM sodium pyruvate, 4 mM L-
glutamine and 1% non-essential amino acids (from 100x ready-to-use stock). Cultures were 
maintained at 37 °C in humidified atmosphere containing 95% air and 5% CO2. 
 
MTT assay: Cytotoxicity was determined by the colorimetric MTT [3-(4,5-dimethyl-2-
thiazolyl)-2,5-diphenyl-2H-tetrazolium bromide] microculture assay. For this purpose, cells 
were harvested from culture flasks by trypsinisation and seeded in 100 μL/well aliquots into 
96-well microculture plates. Cell densities of 1.0 × 103 cells/well (CH1), 2.0 × 103 cells/well 
(SW480) and 3.0 × 103 cells/well (A549) were chosen in order to ensure exponential growth 
of untreated controls throughout the experiment. Cells were allowed to settle and resume 
exponential growth in drug-free complete culture medium for 24 h. Stock solutions of the test 
compounds in DMSO were diluted in complete culture medium and added to the plates (100 
µL/well) where the maximum DMSO content did not exceed 0.5%. After 96 h of exposure, all 
media were replaced with 100 μL/well of MTT/RPMI1640 mixture (six parts of RPMI1640 
medium supplemented with 10% heat-inactivated fetal bovine serum and 4 mM L-glutamine; 
one part of 5 mg/mL MTT reagent in phosphate-buffered saline). After incubation for 4 h, the 
supernatants were removed, and the formazan crystals formed by viable cells were dissolved 
in 150 μL DMSO per well. Optical densities at 550 nm were measured with a microplate 
reader (BioTek ELx808), by using a reference wavelength of 690 nm to correct for unspecific 
absorption. The quantity of viable cells was expressed in terms of T/C values by comparison 
to untreated controls, and 50% inhibitory concentrations (IC50) were calculated from 
concentration-effect curves by interpolation. Evaluation is based on means from three 
independent experiments, each comprising three replicates per concentration level. 
 
3. Results and discussion 
3.1. Synthesis of organometallic Rh(III) complexes and characterization 
 
The RhIII precursor [RhIII(Cp*)(m-Cl)Cl]2 was synthesized according to literature procedures 
by reaction of RhCl3 with pentamethylcyclopentadiene (Cp*) [26]. The maltol-based Rh
III 
complex was obtained according to the procedure described by Abbott et al. [27], which was 
adapted to prepare the analogous allomaltol organometallic complex. The ligand was 
deprotonated by sodium methoxide, followed by conversion with the RhIII dimer at room 
temperature (Scheme 1). The isolated yield was found to be slightly lower (71%) compared to 
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the maltol complex (90%). Recently, Severin and coworkers reported the microwave-assisted 
synthesis of dimeric [RuII(h6-p-cymene)(m-Cl)Cl]2 and [Rh
III(Cp*)(m-Cl)Cl]2 [38] at 140 °C 
which decreased the reaction time from several hours at reflux to minutes. We decided to 
investigate the potential of this powerful tool for the synthesis of organorhodium compounds 
1a and 1b. Several reactions were performed to determine the optimal microwave conditions 
for the coordination reaction. It was found that 60 °C was the optimal temperature for the 
coordination to avoid decomposition processes at higher temperatures or undesired side 
reactions at longer reaction times. The full conversion of the educts was observed after 30 
seconds of irradiation and the complexes were isolated in good yields after work up. 
 Scheme 1 
The organometallic RhIII complexes were characterized by means of standard 
analytical methods and their purity was confirmed by elemental analysis. The 1H NMR 
spectra supported the coordination of the organorhodium fragment. The α-proton next to the 
carbonyl group of the pyrone ring was shifted to higher fields upon coordination of the metal 
ion, whereas the signal assigned to the β-proton next to the ether functionality of the backbone 
was found slightly low-field shifted compared to the free ligands (Figs. S1 and S2), which is 
comparable to the analogues RuII complexes [39].  
Single crystals of 1b were obtained by the slow diffusion method from 
CH2Cl2/diethylether and the result of the X-ray diffraction study is shown in Fig. 1. Crystal 
data, data collection parameters, and structure refinement details are given in Table 1. In this 
complex the RhIII exhibits a pseudo-octahedral geometry and the Cp* moiety occupies three 
coordination sites, while the allomaltolato ligand binds in a bidentate manner via its (O,O) 
donor atoms and the coordination sphere is completed with a chlorido ligand. The 
coordination sphere leads to a chiral center at the rhodium atom and both enantiomers were 
found in the unit cell. In general, the RhIII–ligand bond lengths and angles were found in the 
same range as for [RhIII(Cp*)(maltolato)Cl] 1a [27].  
Fig. 1 
Table 1 
 
3.2. Hydrolytic processes of [RhIII(Cp*)Z3] in absence and presence of chloride ions 
 
The hydrolysis of the half-sandwich complex [RhIII(Cp*)Z3] (Z = H2O or Cl
‒) was studied by 
pH-potentiometric and 1H NMR titrations at ionic strengths such as 0.2 M KNO3, 0.2 and 0.1 
M KCl, and it was found that the equilibria could be reached quite fast in the whole studied 
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pH range (always less than ~6 min). The stoichiometries and overall stability constants of the 
formed dinuclear hydrolysis products were determined based on the findings of both methods 
(Table 2).  
Table 2 
According to literature data [RhIII(Cp*)] appears as [RhIII(Cp*)(H2O)3]
2+ in the absence of 
chloride at acidic pH values following the dissolution of the dimer [RhIII(Cp*)(m-Cl)Cl]2. This 
aqua complex has a pseudooctahedral piano-stool type geometry proved by X-ray 
crystallography [40]. The aqua ligands in [RhIII(Cp*)(H2O)3]
2+ are in the presence of chlorides 
most probably partially or completely substituted by chloride ions, which is reflected in the 
lowered chemical shifts of the methyl groups of the Cp* moiety measured at acidic pH values 
(Fig. 2, Table S1). 
Fig. 2 
While the intensity of the peak assigned to the Cp* protons of [RhIII(Cp*)(Z)3] (Z = H2O or 
Cl‒) decreases, a new peak appears at lower chemical shifts above pH ~5.3 and ~7 in the 
absence and presence of Cl−, respectively (Fig. 2). This peak migrates further to lower 
chemical shifts with increasing pH values up to pH ~8 (with KNO3) or ~9 (with KCl) and 
thereafter it remains unchanged These findings strongly support the formation of a hydroxido 
species in the intermediate pH range. This is a fast exchange process with respect to the NMR 
time scale with the hydroxido complex predominating in the basic pH range. This latter 
species is most probably the tris(m-hydroxido) dinuclear complex [(RhIII(Cp*))2(m-OH)3]
+ 
(annotated [M2H-3]) which forms in both media as its chemical shift is identical independent 
of the presence of nitrate or chloride counter ions (Fig. 2, Table S1). The structure of [M2H‒3] 
was determined by X-ray crystallography [41] and its formation was also shown previously 
by Eisen et al. at high pH in the absence of Cl− [40]. The pH-potentiometric titration curves of 
[RhIII(Cp*)Z3] recorded in 0.2 M KNO3, 0.1 or 0.2 M KCl media reveal that the hydrolysis 
starts at higher pH in the presence of chloride ions and inflection points are seen at pH ca. 5.9, 
7.0 and 7.3, respectively (Figs. 3 and S3). Titration curves also show the consumption of 1.5 
base equivalents per [RhIII(Cp*)Z3] indicating that [M2H‒3] is the major species above pH ~8 
(with KNO3) and ~9 (with 0.2. M KCl). However, the calculated titrations curves could be 
fitted slightly better to the measured ones in all cases by including [(RhIII(Cp*))2(m-OH)2Z2]
 
(i.e. [M2H‒2]) as a minor component in the speciation models (Figs. 3 and S3, Table 2). 
Formation of an intermediate complex [(RhIII(Cp*))2(m-OH)2(H2O)2]
2+ was also assumed by 
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Eisen et al., however the overlapping hydrolytic processes could not be deconvoluted and no 
stability data were provided [40].    
Fig. 3 
Table 2 
Concentration distribution curves were calculated on the basis of the stability 
constants of the hydroxido complexes obtained by pH-potentiometry (see Fig. 2). The 1H 
NMR signals of the monomeric and dinuclear species were separated well enough in the case 
of the nitrate-containing solutions to integrate them and molar fractions of the metal ion could 
be calculated (Fig. 2a), which are in a good agreement with the pH-potentiometry data. The 
stability data (Table 2) and the concentration distribution curves clearly reveal that chloride 
ions suppress the hydrolysis and shift hydrolysis processes to the higher pH range. It is 
noteworthy that the same trend was shown for the isoelectric species [RuII(h6-p-cymene)Z3]
2+ 
[42], although the tendency of [RhIII(Cp*)Z3] to hydrolyze is undoubtedly weaker. 
 
3.3. Solution equilibria of [RhIII(Cp*)Z3] complexes of maltol and allomaltol in chloride-free 
and chloride-containing media 
 
The proton dissociation constants of the studied ligands maltol and allomaltol were 
determined by pH-potentiometry and are in reasonably good agreement with those reported in 
literature (Table 3) [43,44]. The proton dissociation constants of these hydroxypyrone ligands 
can be attributed to the deprotonation of the hydroxyl functional group and allomaltol has the 
lower pKa value. 
Table 3 
The complex formation processes of [RhIII(Cp*)(Z)3] with maltol and allomaltol were 
investigated by the combined use of pH-potentiometric, 1H NMR and UV-Vis titrations in the 
absence and presence of 0.2 M chloride in pure aqueous solutions due to the excellent 
solubility of the complexes (up to 10 mM). The complex formation equilibrium establishes 
quickly in both media and quite similar speciation was found in all cases. The stoichiometries 
of the metal complexes and their overall stability constants furnishing the best fits to the 
experimental data are listed in Table 3. Formation of only mono-ligand complexes such as 
[ML] (as [RhIII(Cp*)(L)Z]) and [MLH‒1] (as [Rh
III(Cp*)(L)H‒1]) was detected when studying 
maltol independent of the conditions but was not observed in the case of allomaltol. 
Representative concentration distribution curves are shown in Fig. 4 for the [RhIII(Cp*)(Z)3]–
allomaltol system in chloride-free medium. It is noteworthy that the hydrolysis product 
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[MLH‒1] of the allomaltol complex could not be detected in the chloride-containing solution. 
Due to the possible coordination of the chloride ions in the species [RhIII(Cp*)Z3], 
[(RhIII(Cp*))2(m-OH)2Z2] and [Rh
III(Cp*)(L)Z] by replacing partly the aqua ligands, the 
stability data for the 0.2 M KCl-containing medium are regarded as conditional stability 
constants and are valid only under the given conditions. 
Fig. 4 
According to the pH-potentiometric titration curves the complex formation with maltol 
starts already at pH ~2 in the nitrate-containing system, while only at pH > 4 in the presence 
of chloride. This is in good agreement with the pH-dependent 1H NMR data (see 
representative spectra for maltol in Fig. 5 in the presence of chloride ions). 
Fig. 5 
A similar trend was seen in the case of allomaltol (Figs. S4, S5). Since slow ligand-exchange 
processes were observed in the 1H NMR spectra of the [RhIII(Cp*)(Z)3]–ligand systems with 
respect to the NMR time scale (t1/2(obs) > ~1 ms), peaks belonging to the protons of the free 
or bound ligand and to the bound or non-bound Cp* moiety could be detected separately. The 
formation of species [MLZ] of maltol can be observed at pH > 4 (Fig. 5). Two parallel 
processes can be detected in the basic pH range, namely the upfield shift of the peak 
belonging to [MLZ], which indicates the formation of the hydrolysis product [MLH‒1], and 
the appearance of signals assigned to free ligand and the non-bound metal moiety due 
decomposition of [MLZ]. The integrated peak areas were converted to molar fractions, which 
were also determined on the basis of the stability constants obtained by pH-potentiometry. 
Fairly good correlations between the data of both methods were observed in the whole pH 
range studied. This is shown exemplary for the [RhIII(Cp*)(H2O)3]–maltol system in chloride-
free medium in Fig. 6. In addition, UV-Vis spectra were also collected for the same system in 
the pH range 2–11.5 and the detected spectral changes of the charge transfer bands (Fig. 6) 
strongly correlate to the formation of the [ML] and [MLH‒1] species.  
 Fig. 6 
In the species [RhIII(Cp*)(L)Z] the maltol and allomaltol coordinate via the bidentate 
(O,O)-donor set as it was shown for [RhIII(Cp*)(maltolato)Cl] [27] and 
[RhIII(Cp*)(allomaltolato)Cl] (Fig. 1) by X-ray crystallography. On the other hand the species 
of the general formula [RhIII(Cp*)(L)H‒1] are considered as mixed hydroxido 
[RhIII(Cp*)(L)(OH)] species formed by deprotonation of the coordinated water molecule or 
(partly) by the replacement of the chlorido ligand in chloride-containing medium. 
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Based on the overall stability constants (Table 3) of the studied [RhIII(Cp*)] 
complexes it can be concluded that the stability of the corresponding species of maltol and 
allomaltol is comparable. The different basicities of the ligands can be taken into 
consideration (log K*, Table 3) according to the following competition reaction for a more 
adequate comparison of the stabilities: 
[RhIII(Cp*)Z3]  + HL  [Rh
III(Cp*)(L)Z] + H+ + 2 Z (Z = H2O or Cl
‒) 
Log K* values demonstrate the similar chelate stability of the complexes of these 
hydroxypyrone ligands. It is noteworthy that chloride ions as competitive ligands can suppress 
the formation of the (O,O)-complexes. This is reflected in the higher pH values where the 
complexation starts (vide supra) in the KCl- over the KNO3-containing medium and in the 
lower log K* values.  
It should also be noted that the predominant formation of the species [MLZ] is found 
in all cases at physiological pH. The molar fraction of this species depends on its total 
concentration as it is shown for the [RhIII(Cp*)(Z)3]–allomaltol system in Fig. 7. Partial 
decomposition can be predicted in the low-micromolar concentration range.  
  Fig. 7 
In the species [RhIII(Cp*)(L)Z] the third coordination site is most probably occupied 
by a water molecule in the absence of chloride. It can be partially (or completely) displaced 
by a chloride ligand in the KCl-containing milieu or the chlorido complex can undergo 
hydrolysis after dissolution. The coordination of the labile chloride results in characteristic 
spectral changes in the UV-Vis spectra of the complexes (Fig. S6), therefore the stepwise 
stability constants (log K’(H2O/Cl
‒) in Table 3) could be estimated for the 
[RhIII(Cp*)L(H2O)]
+ + Cl− [RhIII(Cp*)(L)Cl)] + H2O equilibrium at about neutral pH 
values where [RhIII(Cp*)(L)Z] complexes predominate. Based on the equilibrium constant for 
the maltol complex concentration distribution curves were calculated for [MLZ] species at 
various chloride concentrations (Fig. 8). According to the H2O/Cl
- exchange constants, about 
76 and 61% of the maltolato and 82 and 71% of the allomaltolato complexes are chlorinated 
at neutral pH and 0.2 and 0.1 M chloride concentrations, respectively.  
Fig. 8 
Stability constants of the analogous complexes formed in the [RuII(h6-p-cymene)]–
maltol/allomaltol systems with the stoichiometries [ML] and [MLH‒1] are also available in the 
literature [45,46]. The direct comparison of the overall stability constants of the complexes of 
[RuII(h6-p-cymene)] to those of [RhIII(Cp*)] species shows higher values for [RuII(h6-p-
cymene)] complexes, although the tendency of these metal ions to hydrolyze is significantly 
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different. Thus this fact has to be taken into consideration when the stabilities are considered. 
To indicate the difference in the metal binding ability of maltol towards [RuII(h6-p-cymene)] 
and [RhIII(Cp*)], pM values were computed at various pH values under the same conditions 
(Fig. 9). pM values give the negative logarithm of the equilibrium concentrations of the non-
bound metal ion ([M], [M2H‒2], [M2H‒3]) under the given conditions. Higher pM values 
indicate stronger chelating ability.  
Fig. 9 
The coordination of the ligands to [RuII(h6-p-cymene)] starts at more acidic pH values 
(reflected in the higher log  values of [MLZ] [45,46]) compared with [RhIII(Cp*)]. However, 
the coordination of maltol to [RhIII(Cp*)] becomes more favorable at pH > ~7 owing to the 
less pronounced hydrolysis of this metal ion. It can be also noted that maltol is not able to 
prevent the dissociation of these complexes at pH > ~10.5.  
 
3.4. Cytotoxicity of [RhIII(Cp*)] complexes of maltol and allomaltol 
 
Recently, maltol-derived organometallic complexes were investigated for their anticancer 
potential, however, only moderate cytotoxicity was observed [39,47]. These observations 
were explained by the low stability of the compounds under physiological conditions in the 
presence of biological nucleophiles. Within this work we have shown that coordination of 
hydroxypyrone ligands to [RhIII(Cp*)] leads to complexes with increased stability at neutral 
pH. Therefore, the impact of the organorhodium fragment on cytotoxicity was investigated by 
means of the colorimetric MTT assay in the human cancer cell lines CH1 (ovarian 
carcinoma), SW480 (colon carcinoma) and A549 (non-small cell lung carcinoma) and 
compared to the related [RuII(h6-p-cymene)] complexes.  
 Table 4  
In general, CH1 cells were found to be the most sensitive of the investigated cell lines and a 
moderate cytotoxicity was observed for complexes 1a and 1b with IC50 values of roughly 100 
µM, whereas cell lines SW480 were less and A549 least affected by the compounds, 
corresponding to their more generally lower chemosensitivity. No significant influence of the 
methyl group position on the pyrone ring was observed, in accordance with the virtually 
identical stabilities of the complexes. Furthermore, the cytotoxic potency of 1a was found in 
the same range as that of the analogous [RuII(h6-p-cymene)] complexes [21], but 1b was 
16 
found to be about twice as potent than its RuII counterpart in all three cell lines, based on 
comparison of IC50 values.  
 
4. Conclusions 
 
The syntheses of [RhIII(Cp*)] complexes of maltol and allomaltol either under standard and 
microwave conditions are presented. The complexes were obtained by the reaction of the 
deprotonated 3-hydroxy-4-pyrones with the rhodium precursor [RhIII(Cp*)(m-Cl)Cl]2 and it 
was possible to reduce the reaction time from several hours to about 30 seconds under 
microwave conditions. The cytotoxicity of the complexes was studied in the human cancer 
cell lines (CH1, SW480 and A549). They were found to exhibit moderate to low cytotoxicity 
with IC50 values of 80–320 mM. As these complexes are well water soluble (up to 10 mM), 
the solution speciation of [RhIII(Cp*)] complexes of maltol and allomaltol could be 
characterized in aqueous solution via a combined approach using pH-potentiometry, 1H NMR 
spectroscopy and UV-Vis spectrophotometry in the absence and presence of chloride ions. 
The hydrolytic behavior of the species [RhIII(Cp*)(H2O)3]
2+ was also studied and formation 
constants for the dimer hydroxido complexes [(RhIII(Cp*))2(m-OH)3]
+ and [(RhIII(Cp*))2(m-
OH)2Z2] (Z = H2O/Cl
‒) were determined at various chloride concentrations. Exclusive 
formation of the mono-ligand complexes [ML] and [ML(OH)] with moderate stability were 
detected. No significant difference between the complex stabilities of the two hydroxypyrones 
was observed. Chloride ions act as competitive ligands and are able to suppress the formation 
of [RhIII(Cp*)] complexes to some extent. Notably, species of the type [MLZ] were observed 
to be predominant at physiological pH, and only partial decomposition of the complexes is 
expected on the basis of the determined stability constants in the low-micromolar 
concentration range. Formation of the mixed hydroxido complex [ML(OH)] could be 
characterized by determination of relatively high pKa values (9.41‒10.60). The aquation of 
[RhIII(Cp*)(L)Cl] complexes may have impact on the biological activity as Cl‒/H2O exchange 
can take place under physiological conditions to different extent depending on the chloride 
concentrations. Thus, this co-ligand exchange equilibrium was also studied by UV-Vis 
spectrophotometry. Based on the constants it can be predicted that, e.g. ~61% of the maltolato 
complex exists as the chloride complex at 0.1 M chloride concentration in human blood, and 
the level of aquation should increase in the cytosol or in the nucleus due to their diminished 
chloride concentrations. This has important impact on the speciation in biological systems. 
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The in vivo biological activity of an anticancer drug candidate is strongly influenced by 
pharmacokinetic and pharmacodynamic parameters; therefore the interactions with blood 
serum proteins such as albumin or with feasible final targets such as DNA or e.g. thiolato side 
chain containing proteins are essential binding events and are currently investigated in our 
laboratories.  
 
5. Abbreviations 
 
1a chlorido[2-methyl-3-(oxo-κO)-pyran-4(1H)-onato-κO](η5-1,2,3,4,5-
pentamethylcyclopentadienyl)rhodium(III) 
1b chlorido[2-methyl-5-(oxo-κO)-pyran-4(1H)-onato-κO](η5-1,2,3,4,5-
pentamethylcyclopentadienyl)rhodium(III) 
allomaltol  5-hydroxy-2-methyl-pyran-4(1H)-one 
maltol   3-hydroxy-2-methyl-pyran-4(1H)-one 
Cp*   pentamethylcyclopentadiene  
MEM    minimum essential medium 
MTT   3-(4,5-dimethyl-2-thiazolyl)-2,5-diphenyl-2H-tetrazolium bromide 
[RhIII(Cp*)]  rhodium(III)-η5-pentamethylcyclopentadienyl 
UV-Vis  UV-visible  
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Legends to Figures/Charts  
 
Chart 1 Chemical structures of maltol (a), allomaltol (b) and [RhIII(Cp*)(H2O)3]
2+ (c). 
 
Scheme 1 Synthesis of the organometallic RhIII complexes by A) standard procedure (18 h at room 
temperature) and B) microwave assisted preparation (30 s, < 10 W, 60 °C). 
 
Fig. 1 ORTEP view of [RhIII(Cp*)(allomaltolato)Cl] 1b at 50% probability level. 
 
Fig. 2 pH-Dependent 1H NMR spectra and concentration distribution curves of [RhIII(Cp*)Z3] (Z = 
H2O or Cl
‒; M = RhIII(Cp*)) in chloride-free (a) and chloride-containing (b) solutions (left side). 
Concentration distribution curves for [MZ3] (grey line), its hydroxido complexes (black lines) and 
summarized fractions for the hydroxido complexes (dashed line) calculated by the use of their overall 
stability constants. Molar fractions based on the 1H NMR peak integrals: [M(H2O)3] (●) and [M2H‒i] 
(○, i = 2 or 3) (right side). {cM = 1 mM; T = 25 ˚C; I = 0.20 M (KNO3 or KCl); 10% D2O}. 
 
Fig. 3 Representative pH-potentiometric titration curve of [RhIII(Cp*)(H2O)3] in chloride-free aqueous 
solution (×) and calculated curves confirming  (grey solid line) or disproving  (grey dotted line) the 
existence of [M2H‒2] hydroxido species besides [M2H‒3]. {cM  = 1.2 mM; T = 25 ˚C; I = 0.20 M 
(KNO3)}.  
 
Fig. 4 Concentration distribution curves of the [RhIII(Cp*)(H2O)3]–allomaltol system in chloride-free 
aqueous solution. {cM = cL = 1 mM; T = 25 ˚C; I = 0.20 M (KNO3)}.  
 
Fig. 5 Low (a) and high (b) field regions of 1H NMR spectra of the [RhIII(Cp*)Z3]–maltol system in 
chloride-containing aqueous solution recorded at various pH values. The CH(5) (maltol) (a) and CH3 
(Cp*) (b) proton peaks are highlighted. {cM = cL = 1 mM; T = 25 ˚C; I = 0.20 M (KCl); 10% D2O; i = 
2 or 3; Z = H2O or Cl
-}.  
 
Fig. 6 Concentration distribution curves of the [RhIII(Cp*)(H2O)3]–maltol system in chloride-free 
aqueous solution calculated on the basis of the overall stability constants and 1H NMR peak integrals: 
bound (●) and free (○) ligand together with the pH-dependence of the absorbance values at 430 nm for 
the same system (×). {cmaltol = 1 mM (
1H NMR, 10% D2O) and 220 mM (UV-Vis); M : L = 1:1; l = 1 
cm; T = 25.0 ˚C, I = 0.20 M (KNO3) }. 
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Fig. 7 Concentration distribution curves of the [RhIII(Cp*)Z3]–allomaltol (1:1) system in chloride-free 
(grey lines) and chloride-containing (black lines) aqueous solutions as a function of the analytical 
(total) complex concentrations at pH 7.40. {T = 25 ˚C; I = 0.20 M (KCl or KNO3); Z = H2O or Cl
‒}.  
 
Fig. 8 Chloride-dependent absorbance values at 430 nm (Ο) and calculated concentration distribution 
curves for the water/chloride exchange process of the [RhIII(Cp*)(H2O)3]–maltol system at 
physiological pH. {cM = cL = 0.50 mM; T = 25 ˚C; pH = 7.40)}. 
 
Fig. 9 pH-dependence of pM values calculated for the [RhIII(Cp*)Z3]–maltol (solid line) and [Ru
II(h6-
p-cymene)Z3]–maltol (dashed line) systems under identical conditions. pM = –log[M]; where [M] is 
the equilibrium concentration of the ligand-free, non-bound metal ions. {cM = 1 mM; M:L = 1:1; T = 
25 ˚C; I = 0.20 M (KCl)} Calculation for the RuII-containing system is based on data from [45]. 
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Table 1 
Crystal data and details of data collection for [RhIII(Cp*)(allomaltolato)Cl] 1b 
   
Compound 1b 
Empirical formula      C16H20ClO3Rh 
Formula weight / g/mol 398.68 
Temperature / K 100(2) 
Wavelength / Å 0.71073 
Crystal size / mm 0.15 × 0.06 × 0.04  
Crystal system  monoclinic 
space group        P21/c 
a / Å 8.0842(3) 
b / Å 10.1198(4) 
c / Å 19.2712(8) 
 / ° 90.00 
β/ ° 96.4400(13) 
γ / ° 90.00 
Volume / Å3 1566.64(11) 
Z 4 
Calculated density / mg/m3 1.690 
24 
Absorption coefficient / mm-1 1.267  
F(000)          808 
 range for data collection    2.28–25.34° 
Index ranges           -9 ≤ h ≤ 9 
-12≤ k ≤ 12 
-23 ≤ l ≤ 23 
Reflections collected / unique     26776  / 2867 
Data / restraints / parameters     2867 / 0 / 196 
R(int) 0.0238 
Goodness-of-fit on F2 a 1.030 
Final R indices [I>2σ(I)] b  
R1 0.0331 
wR2 0.0946 
a GOF = {S[w(Fo
2 – Fc
2)2] /(n – p)}1/2, where n is the number of 
reflections and p is the total number of parameters refined. 
b R1 = SFo - Fc/SFo.  wR2 = {S[w(Fo
2 – Fc
2)2]/S[w(Fo
2)2]}1/2 
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Table 2 
Overall stability constants (log) of the [RhIII(Cp*)Z3]-hydroxido species at various ionic 
strengths (I) determined by pH-potentiometry {T = 25 C}.a 
 0.20 M KCl 0.10 M KCl 0.20 M KNO3 
log  (M2H‒2)
 b -11.12(1) -10.48(2) -8.53(7) 
log  (M2H‒3)
 b -19.01(1) -18.07(3) -14.26(4) 
a Standard deviations (SD) in parenthesis, values determined in 
aqueous solutions. b As H+ is defined as a component, H‒i indicates 
the deprotonation of “i” coordinated H2O molecules, or coordination 
of hydroxides. 
 
 
26 
Table 3 
Proton dissociation constants (pKa) of maltol and allomaltol and overall stability constants 
(log ) of their [RhIII(Cp*)Z3] complexes in chloride-containing and chloride-free solutions 
determined by pH-potentiometry {T = 25 C; I = 0.20 M}.a 
 maltol (1a) allomaltol (1b) 
 0.20 M KCl 0.20 M KNO3 0.20 M KCl 0.20 M KNO3 
pKa (ligand) 8.44
b 8.45(1) 7.97c 7.97(1) 
log [MLZ]d 6.73(1) 8.45(1) 6.34(1) 8.01(1) 
log [MLH‒1]
e -3.87(9) -1.06(4) ‒ -1.40(7) 
pK [MLZ] 10.60 9.51 ‒ 9.41 
log K* f -1.71 0.00 -1.63 0.04 
log K (H2O/Cl
‒) g 1.17(1) 1.38(1) 
a Standard deviations (SD) in parenthesis, values determined in aqueous solutions. b Data 
taken from [42]. c Data taken from [44] d Z = H2O or Cl
‒ for chloride-containing samples; 
Z = H2O for chloride-free media. 
e As H+ is defined as a component, H−1 indicates the 
deprotonation of a coordinated H2O molecule, or coordination of OH
−. f log K* = log  
[MLZ] − pKa (HL). 
g [RhIII(Cp*)(L)(H2O)]
+ + Cl−  [RhIII(Cp*)(L)(Cl)] + H2O 
determined at various total chloride concentrations by UV-Vis spectrophotometry. 
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Table 4 
In vitro cytotoxicity (IC50 values in µM) of the [Rh
III(Cp*)] complexes of maltol 1a and 
allomaltol 1b compared to their [RuII(h6-p-cymene)] analogues a 
 [Ru
II(h6-p-cymene)] b [RhIII(Cp*] 
 maltol allomaltol 1a (maltol)  1b (allomaltol) 
CH1 81 ± 14 239 ± 22 120 ± 16 104 ± 20 
SW480 159 ± 41 359 ± 119 178 ± 26 145 ± 5 
A549 482 ± 20 518 ± 65 306 ± 34 280 ± 54   
a 96 h exposure. b Data taken from [39]. 
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